Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
6.57
+0.07 (1.08%)
At close: May 18, 2026, 4:00 PM EDT
6.56
-0.01 (-0.15%)
After-hours: May 18, 2026, 7:41 PM EDT
Evolus Employees
Evolus had 350 employees as of March 31, 2026. The number of employees increased by 16 or 4.79% since the number was last reported on December 31, 2025.
Employees
350
Change
16
Growth
4.79%
Revenue / Employee
$862,260
Profits / Employee
-$124,066
Market Cap
432.67M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 350 | 16 | 4.79% |
| Dec 31, 2025 | 334 | 2 | 0.60% |
| Dec 31, 2024 | 332 | 59 | 21.61% |
| Dec 31, 2023 | 273 | 58 | 26.98% |
| Dec 31, 2022 | 215 | 48 | 28.74% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tilray Brands | 2,842 |
| Amphastar Pharmaceuticals | 1,976 |
| Canopy Growth | 960 |
| Emergent BioSolutions | 900 |
| Organogenesis Holdings | 854 |
| Kamada | 462 |
| Akebia Therapeutics | 194 |
| Aquestive Therapeutics | 147 |
EOLS News
- 7 days ago - Evolus announces commercial launch of Estyme in Europe - TheFly
- 7 days ago - Evolus Announces Commercial Launch of Estyme® Injectable Hyaluronic Acid Gels in Europe - Business Wire
- 14 days ago - Evolus Earnings Call Transcript: Q1 2026 - Transcripts
- 14 days ago - Evolus reports Q1 EPS (16c), consensus (12c) - TheFly
- 14 days ago - Evolus Reports First Quarter 2026 Financial Results; Company Delivers Second Consecutive Quarter of Positive Adjusted EBITDA and Reaffirms Full-Year Outlook - Business Wire
- 14 days ago - Weight-loss revolution sparks new appetite for aesthetics firms - Reuters
- 4 weeks ago - Evolus Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 4 weeks ago - Evolus to Report First Quarter Financial Results on May 4, 2026 - Business Wire